12-01-2009 -PTS, Inc. Announces Historic Milestones in Global Sales of the CardioChek® and CardioChek PA® Test System

"Polymer Technology Systems, Inc. (PTS, Inc.), a leading global provider of point-of-care diagnostic products to the healthcare industry, announced today that the company achieved a number of record-setting global sales milestones. The CardioChek and CardioChek PA instrument platforms provide blood chemistry information including Lipids and Glucose, for cholesterol and diabetes testing. The company reports that a milestone of more than 200,000 instruments have been sold in over 100 countries including the U.S. In addition, the company reports over 9 million Lipid Panel Tests and over 35 million test strips have been sold worldwide."

Click here for full article

08-12-2009 - PTS, Inc. Hails New Study Linking High Cholesterol Levels to Increased Risk for Developing Alzheimer's Disease or Vascular Dementia

"Polymer Technology Systems, Inc. (PTS, Inc.), manufacturer of the CardioChek® PA point-of-care instrument and the CardioChek® home cholesterol analyzer, released a statement today hailing the new study by Kaiser Permanente that suggests that high cholesterol levels are a significant risk factor for developing dementia and Alzheimer’s Disease (AD) later in life."

Click here for full article

04-20-2009 - PTS, Inc. Introduces Connectivity Software Solution, CardioChek Link™

"Polymer Technology Systems Inc., (PTS, Inc.) a global provider of point-of-care diagnostic products to the healthcare industry, announced today the introduction of CardioChek Link™, software developed to interface the company’s premier cholesterol test system, CardioChek® PA, with a windows-based desktop computer. With this new software solution, CardioChek PA point-of-care instrument users will be able to transmit cholesterol and other test results directly from the instrument to a personal computer."
Click here for full article